BIOMAT Database Logo BIOMAT Database Logo

Biopharmaceutical studies on the clinical inequivalence of two carbutamide tablets. 1982

F Saffar, and H Ogata, and A Ejima

UI MeSH Term Description Entries
D008297 Male Males
D002271 Carbutamide A sulfonylurea antidiabetic agent with similar actions and uses to CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Aminophenurobutane,Butylcarbamide,Glybutamide,Sulfaninylbutylurea,Bucarban,Bukarban,Diabetal,Glucidoral,Oranil,Oranyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D013810 Therapeutic Equivalency The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease. Bioequivalence,Clinical Equivalency,Equivalency, Therapeutic,Generic Equivalency,Clinical Equivalencies,Equivalencies, Clinical,Equivalencies, Therapeutic,Equivalency, Clinical,Therapeutic Equivalencies,Bioequivalences,Equivalencies, Generic,Equivalency, Generic,Generic Equivalencies

Related Publications

F Saffar, and H Ogata, and A Ejima
Toxicological studies on carbutamide.
January 1957, Diabetes,
F Saffar, and H Ogata, and A Ejima
[Biopharmaceutical aspects of butamide tablets].
January 1978, Farmatsevtychnyi zhurnal,
F Saffar, and H Ogata, and A Ejima
[Biopharmaceutical characteristics of digoxin tablets].
June 1976, Bollettino chimico farmaceutico,
F Saffar, and H Ogata, and A Ejima
Effect of mixing on the biopharmaceutical properties of sulfadiazine tablets.
May 1988, Il Farmaco; edizione pratica,
F Saffar, and H Ogata, and A Ejima
Studies on the mechanism of action of carbutamide.
July 1958, Endokrinologie,
F Saffar, and H Ogata, and A Ejima
[Biopharmaceutical evaluation of calcium gluconate tablets].
January 1974, Farmatsiia,
F Saffar, and H Ogata, and A Ejima
[Clinical laboratory tests in the presence of carbutamide Preliminary studies].
November 1983, Acta pharmaceutica Hungarica,
F Saffar, and H Ogata, and A Ejima
Generic inequivalence--clinical observations.
January 1971, Acta pharmacologica et toxicologica,
F Saffar, and H Ogata, and A Ejima
Biopharmaceutical evaluation of formulated metformin/rosiglitazone tablets.
April 2010, Drug discoveries & therapeutics,
F Saffar, and H Ogata, and A Ejima
[Physicochemical and biopharmaceutical characteristics of trimag tablets].
January 1988, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Copied contents to your clipboard!